Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 30 (Search time: 0.002 seconds).
Item hits:
Issue DateTitleAuthor(s)
1-Sep-2013Reduced indinavir exposure during pregnancyTim R. Cressey; Brookie M. Best; Jullapong Achalapong; Alice Stek; Jiajia Wang; Nantasak Chotivanich; Prapap Yuthavisuthi; Pornnapa Suriyachai; Sinart Prommas; David E. Shapiro; D. Heather Watts; Elizabeth Smith; Edmund Capparelli; Regis Kreitchmann; Mark Mirochnick
19-Dec-2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit; Tim R. Cressey; Edmund Capparelli; Virat Sirisanthana; Petronella Muresan; Suchat Hongsiriwon; Chaiwat Ngampiyaskul; Chanin Limwongse; Orasri Wittawatmongkol; Linda Aurpibul; Bill Kabat; Mari Pat Toye; Mary Elizabeth Smith; Achara Eksaengsri; Kenneth McIntosh; Ram Yogev
1-Feb-2011Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavirTim R. Cressey; Saik Urien; Deborah Hirt; Guttiga Halue; Malee Techapornroong; Chureeratana Bowonwatanuwong; Prattana Leenasirimakul; Jean Marc Treluyer; Gonzague Jourdain; Marc Lallemant
1-Oct-2012Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam; Desiré Kabamba; Tim R. Cressey; David Burger; Francesca T. Aweek; Edward P. Acosta; Stephen A. Spector; Edmund V. Capparelli
1-Jan-2014The role of formulation on the pharmacokinetics of antiretroviral drugsDiane Et Bastiaans; Tim R. Cressey; Herman Vromans; David M. Burger
1-Dec-2012Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavirKulkanya Chokephaibulkit; Maneeratn Nuntarukchaikul; Wanatpreeya Phongsamart; Orasri Wittawatmongkol; Keswadee Lapphra; Nirun Vanprapar; Tim R. Cressey
1-Dec-2012Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem; Tim R. Cressey; Pattamawan Prapaithong; Yardpiroon Tawon; Ekawat Pasomsub; Chutatip Srichunrusami; Thawinee Jantararoungtong; Marc Lallement; Wasun Chantratita
1-Dec-2012Developmental pharmacokinetic changes of lamivudine in infants and childrenAdriana H. Tremoulet; Mina Nikanjam; Tim R. Cressey; Kulkanya Chokephaibulkit; Ross McKinney; Mark Mirochnick; Edmund V. Capparelli
1-Oct-2012Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall; Tim R. Cressey; Jennifer R. King
1-Jan-2016Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancyPatumrat Sripan; Sophie Le Coeur; Lily Ingsrisawang; Tim R. Cressey; Naïm Bouazza; Frantz Foissac; Nicole Ngo-Giang-Huong; Patrinee Traisathit; Ussanee Srirompotong; Orada Patamasingh Na Ayudhaya; Achara Puangsombat; Jantana Jungpipun; Kanokwan Jittayanun; Jean Marc Tréluyer; Gonzague Jourdain; Marc Lallemant; Saïk Urien